3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
5
Head and Neck Neoplasms
5
Salivary Gland Neoplasms
3
Radiation Injuries
3
Carcinoma, Hepatocellular
3
Testicular Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Laryngeal Neoplasms
2
Esthesioneuroblastoma, Olfactory
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Medullary
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Testicular Germ Cell Tumor
1
Stomatitis
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Nivolumab
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Ipilimumab
1
Immunoglobulin G
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
sargramostim
×
Head & Neck
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled